Efficacy and Safety of Treating Refractory Bone and Soft Tissue Sarcoma with Anlotinib in Different Treatment Patterns

Figure 5

Kaplan–Meier curve of progression-free survival and overall survival for patients with soft tissue sarcoma of different subtypes.

(a)

(b)